News
A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...
Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.
1hon MSN
Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has ...
In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.
Adweek on MSN13h
Eli Lilly's Big Task: Become a Loved and Trusted Pharma BrandA new film from Eli Lilly sounds like a recruitment ad, but it doubles as a brand manifesto to showcase the pharmaceutical ...
CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...
Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.
Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback